Dr. Francesc Solé is one of the world's leading authorities in Cytogenetics in Myelodysplastic Syndromes (MDS). He was involved in the recent IPSS-R and IPSS-M scoring systems at MDS. Dr. Solé is a reviewer for the following journals: American Journal of Hematology, Blood, British Journal of Haematology, Cancers, Genes Chromosomes and Cancer, Haematologica, Leukemia, Leukemia Research, and Leukemia and Lymphoma. He is an associate professor at the Pompeu Fabra University (Barcelona), the University of Barcelona (UB) and the Autonomous University of Barcelona (Bellaterra). From 1996 to 2008 he was coordinator of the Spanish Working Group on Cytogenetics in Hematology (GCECGH) of the SEHH (Spanish Society of Hematology and Hemotherapy). From 2004 to 2012 he was a member of the Eurogenest Hematology Quality Control Steering Committee. Since its creation, he is a member of the Spanish Group of Myelodysplastic Syndromes (GESMD) and of the world MDS group, IWG-PM, and since 2012 he is a member of the ELN. Currently, he is the Scientific Coordinator of the Josep Carreras Leukaemia Research Institute Can Ruti Location (Badalona), Coordinator of the Sample Handling Circuit Unit for patients with haematological cancer, Cytogenetics Unit and Microarray Unit and Head of Group of the MDS at IJC. He is the author of more than 350 peer-reviewed publications and serves on multiple national committees and scientific advisory boards for numerous for-profit and non-profit organizations.